IDEAYA Biosciences, Inc. (IDYA)
34.08
-1.26
(-3.57%)
USD |
NASDAQ |
Dec 09, 16:00
34.11
+0.03
(+0.09%)
After-Hours: 20:00
IDEAYA Biosciences EPS Diluted (Quarterly): 1.330 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 2.434 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| GT Biopharma, Inc. | -0.8268 |
| Zymeworks, Inc. | -0.2587 |
| Belite Bio, Inc. | -0.6529 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 119.24M |
| Revenue (Quarterly) | 207.83M |
| Total Expenses (Quarterly) | 88.59M |
| Enterprise Value | 2.228B |
| Gross Profit Margin (Quarterly) | 99.50% |
| Profit Margin (Quarterly) | 57.37% |
| Earnings Yield | -5.44% |
| Normalized Earnings Yield | -5.444 |